Pfizer Vaccine receives FDA approval: Will we need a second vaccine?

MMR Vaccination: A Potential Strategy to Reduce Severity and Mortality of COVID-19 Illness

Measles epidemics leading to measles elimination programs with mass MMR vaccination may explain part of the observed international variations, suggesting that MMR vaccine may provide strong protection from COVID-19 spread and mortality. Read what Dr. Ashford has to say on the subject.

Traditional measures of social distancing, sanitation like hand washing – wearing masks, and contact tracing have been implemented with variable success. However, 3 characteristics of COVID-19: 1) international variation; 2) age-related mortality; and 3) sequence homology between the fusion proteins of SARS-CoV-2 and measles and mumps viruses, and sequence homology between the Macro domains of SARS-CoV-2 and the rubella virus, suggest the Measles-Mumps-Rubella (MMR) vaccine may mitigate COVID-19 spread and severity.

Read the whole article here: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583585/

These findings suggest the MMR vaccine may protect against COVID-19, including high-risk individuals, such as elderly with comorbidities, and health care workers and first responders with COVID-19 patients, especially individuals living in long-term care facilities and the related institutional staff.

Measles epidemics leading to measles elimination programs with mass MMR vaccination may explain part of the observed international variations, suggesting that MMR vaccine may provide strong protection from COVID-19 spread and mortality.